LACTOBACILLUS RHAMNOSUS RHT-3201 CONJUGATED TO POLYSACCHARIDE POLYMER BINDER, AND USE THEREOF FOR PREVENTION OR TREATMENT OF ATOPIC DISEASES
    7.
    发明申请
    LACTOBACILLUS RHAMNOSUS RHT-3201 CONJUGATED TO POLYSACCHARIDE POLYMER BINDER, AND USE THEREOF FOR PREVENTION OR TREATMENT OF ATOPIC DISEASES 审中-公开
    LACTOBACILLUS RHAMNOSUS RHT-3201结合多糖聚合物粘合剂,并用于预防或治疗原发性疾病

    公开(公告)号:US20170051247A1

    公开(公告)日:2017-02-23

    申请号:US15344958

    申请日:2016-11-07

    摘要: The present invention relates to heat-killed Lactobacillus rhamnosus conjugated to a polysaccharide polymer binder, a preparation method therefor and a use thereof. The heat-killed Lactobacillus rhamnosus conjugated to a polysaccharide polymer binder of the present invention has an excellent therapeutic effect for atopic diseases, and particularly has high industrial applicability because membrane adhesion competitiveness, which is an advantage of existing lactic acid bacteria, is significantly improved, thereby exhibiting dermatitis preventing, alleviating and treating effects of the same level as steroid-based drugs.

    摘要翻译: 本发明涉及与多糖聚合物粘合剂缀合的热灭活的鼠李糖乳杆菌,其制备方法及其用途。 与本发明的多糖聚合物粘合剂结合的热灭活的鼠李糖乳杆菌对特应性疾病具有优异的治疗效果,特别是具有高的工业实用性,因为作为现有乳酸菌的优点的膜粘附竞争力显着提高, 从而表现出与类固醇类药物相同水平的皮炎预防,缓解和治疗效果。